OCULAR THERAPEUTIX, INC. RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • February 28th, 2022 • Ocular Therapeutix, Inc • Pharmaceutical preparations
Ocular Therapeutix, Inc. (the “Company”) hereby grants the following restricted stock units pursuant to its 2021 Stock Incentive Plan. The terms and conditions attached hereto are also a part hereof.
OCULAR THERAPEUTIX, INC. STOCK OPTION AGREEMENTStock Option Agreement • February 28th, 2022 • Ocular Therapeutix, Inc • Pharmaceutical preparations
Ocular Therapeutix, Inc. (the “Company”) hereby grants the following stock option pursuant to its 2021 Stock Incentive Plan. The terms and conditions attached hereto are also a part hereof.
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • February 28th, 2022 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Delaware
This Amendment No. 1 to License Agreement (this “Amendment”) by and between Ocular Therapeutix, Inc., a corporation organized and existing under the laws of Delaware with a principal place of business at 24 Crosby Drive, Bedford, MA 01730 (‘Ocular”), and Affamed Therapeutics (HK) Limited, a corporation duly organized and existing under the laws of Hong Kong, with a principal place of business at Room 3306-3307, Two Exchange Square, 8 Connaught, Hong Kong (“AffaMed”), is made and entered into as of October 28, 2021 (the “Amendment Effective Date”).
